Thomas E. Frederick

An Update on the Nitrogen Heterocycle Compositions and Properties of U.S. FDA-Approved Pharmaceuticals (2013–2023)

Targeting ROS in cancer: rationale and strategies

Prediction of New Stabilizing Mutations Based on Mechanistic Insights from Markov State Models

Designing small molecules to target cryptic pockets yields both positive and negative allosteric modulators